LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...

LeMaitre Vascular Inc (LMAT) Q3 2024 Earnings Call Highlights: Robust Sales Growth and ...

Q4 guidance includes 14% sales growth, 68% gross margin, $13.3M operating income, and $0.49 EPS. CEO George LeMaitre addresses OUS price and unit increases and assures sufficient inventory due to no backorder policy.

Read More

Did you find this insightful?